Assessing the Efficacy and Impact of Ambient AI Scribes in Healthcare
Launched by UNIVERSITY OF SASKATCHEWAN · Aug 2, 2025
Trial Information
Current as of November 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how using ambient AI scribes—computer programs that help doctors by automatically taking notes during patient visits—affects doctors’ workload, feelings of burnout, and their interactions with patients. The goal is to see whether these AI tools can help reduce the stress and amount of work doctors have, and if they change how doctors and patients communicate during appointments.
Doctors who work in family medicine or any other specialty and see patients in a clinic at least two days a week may be eligible to join, as long as they plan to stay in their practice during the study. Participants will be randomly assigned to either use the AI scribe or not use it for about two weeks. Doctors will complete surveys about their workload and burnout before and during the study, and their patients will also be asked to share their experiences after each visit. This study hopes to better understand if AI scribes can improve doctors’ work life and patient care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Physicians from family medicine or any specialty
- • Physicians who regularly see patients in a clinic setting at least 2 days per week
- Exclusion Criteria:
- • Physicians who are planning to leave their practice during the study period
About University Of Saskatchewan
The University of Saskatchewan is a leading research institution dedicated to advancing health sciences through innovative clinical trials and studies. With a commitment to improving patient outcomes, the university leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous and ethically sound research. By fostering collaborations among researchers, healthcare professionals, and industry partners, the University of Saskatchewan aims to translate scientific discoveries into practical applications that enhance healthcare delivery and contribute to the well-being of communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Scott Adams, MD, PhD, MEd, FRCPC
Principal Investigator
University of Saskatchewan College of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported